← Leaderboards
Mitzi Michelle Gonzales
University Of Texas At Austin
$4,270,725
Attributed
$10,693,143
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,693,143 · 5
By mechanism
R01$10,392,722 · 3
P30$225,604 · 1
F31$74,817 · 1
Top collaborators
- Zachary Beattie4 shared
- Sara Elyse Espinoza2 shared
- Mohamad Habes2 shared
- Nicolas Musi2 shared
- Juan B Toledo Atucha2 shared
Most similar at University Of Texas At Austin
Same institution · by research overlap
- Eugene V Shakirov$2,551,272
- Debra J. Umberson$8,189,229
- Grace Choi Lee$637,492
- Elliot Max Tucker-Drob$11,296,973
- Richard M Crooks$2,426,826
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCognitionUnited StatesDementiaPreventAgingAttenuatedPrevalencePathway InteractionsS Disease Related DementiaTechnologyCognitiveInsightImpaired CognitionResponseRisk FactorsPatternNeuroimagingAdultMonitorBehavioralHispanic PopulationsBloodInvestigation
Grant awards (11)
Cerebral tau deposition and comorbid cerebrovascular disease across the Alzheimer's disease continuum in Mexican Americans$2,810,962
R01 · FY2025 · AG
Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with Metformin$797,023
R01 · FY2025 · AG
Characterizing Older Mexican (American) Participation in Activity Digitally, Reliably, and Ecologically with the CART Platform (COMPADRE CART): Implications for Cognition and ADRD$716,325
R01 · FY2025 · AG · contact PI
Pilot and Exploratory Studies Core$225,604
P30 · FY2025 · AG · contact PI
Cerebral tau deposition and comorbid cerebrovascular disease across the Alzheimer's disease continuum in Mexican Americans$2,919,399
R01 · FY2024 · AG
Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with Metformin$828,960
R01 · FY2024 · AG
Characterizing Older Mexican (American) Participation in Activity Digitally, Reliably, and Ecologically with the CART Platform (COMPADRE CART): Implications for Cognition and ADRD$780,520
R01 · FY2024 · AG · contact PI
Characterizing Older Mexican (American) Participation in Activity Digitally, Reliably, and Ecologically with the CART Platform (COMPADRE CART): Implications for Cognition and ADRD$756,419
R01 · FY2023 · AG · contact PI
Characterizing Older Mexican (American) Participation in Activity Digitally, Reliably, and Ecologically with the CART Platform (COMPADRE CART): Implications for Cognition and ADRD$783,114
R01 · FY2022 · AG · contact PI
Neuroimaging Obesity-Related Brain Vulnerability in Older Adults$37,681
F31 · FY2013 · AG · contact PI
Neuroimaging Obesity-Related Brain Vulnerability in Older Adults$37,136
F31 · FY2012 · AG · contact PI